144 related articles for article (PubMed ID: 8486948)
1. Inhibition of lipid A- and lipopolysaccharide-induced cytokine secretion, B cell mitogenesis, and lethal shock by lipid A-specific murine monoclonal antibodies.
Ramachandra RN; Berczi A; Sehon AH; Berczi I
J Infect Dis; 1993 May; 167(5):1151-9. PubMed ID: 8486948
[TBL] [Abstract][Full Text] [Related]
2. Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies: comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A.
Cornelissen JJ; Mäkel I; Algra A; Benaissa-Trouw BJ; Schellekens JF; Kraaijeveld CA; Verhoef J
J Infect Dis; 1993 Apr; 167(4):876-81. PubMed ID: 8450253
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to salmonella lipopolysaccharide: functional analysis of anti-lipid A antibodies.
Ward DC; Michalek SM; McGhee JR
Clin Exp Immunol; 1988 Apr; 72(1):157-63. PubMed ID: 3293850
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactive murine monoclonal antibodies directed against the core/lipid A region of endotoxin inhibit production of tumor necrosis factor.
Mayoral JL; Dunn DL
J Surg Res; 1990 Oct; 49(4):287-92. PubMed ID: 1699085
[TBL] [Abstract][Full Text] [Related]
5. A novel synthetic lipid A analog with low endotoxicity, DT-5461, prevents lethal endotoxemia.
Sato K; Yoo YC; Fukushima A; Saiki I; Takahashi TA; Fujihara M; Tono-Oka S; Azuma I
Infect Immun; 1995 Aug; 63(8):2859-66. PubMed ID: 7622206
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
Nys M; Cloes JM; Demonty J; Joassin L
J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
[TBL] [Abstract][Full Text] [Related]
7. Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice.
Cornelissen JJ; Maassen K; van Emst L; Weers PM; Harmsen M; Benaissa-Trouw BJ; Oosterlaken TA; Kraaijeveld CA; Verhoef J
Immunology; 1993 Aug; 79(4):673-80. PubMed ID: 8406595
[TBL] [Abstract][Full Text] [Related]
8. Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide.
Warren HS; Amato SF; Fitting C; Black KM; Loiselle PM; Pasternack MS; Cavaillon JM
J Exp Med; 1993 Jan; 177(1):89-97. PubMed ID: 8418211
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide (LPS)-reactive monoclonal antibodies fail to inhibit LPS-induced tumor necrosis factor secretion by mouse-derived macrophages.
Chia JK; Pollack M; Guelde G; Koles NL; Miller M; Evans ME
J Infect Dis; 1989 May; 159(5):872-80. PubMed ID: 2651532
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of Shwartzman-inducing activity by antibodies recognizing the Re core or lipid A structures of lipopolysaccharide from Salmonella minnesota R595 and Pseudomonas vesicularis JCM1477.
Mashimo J; Mizutani T; Mita A; Kasai N
Microbiol Immunol; 1991; 35(6):423-34. PubMed ID: 1921759
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the immune response to lipopolysaccharide. Existence of an interspecies cross-reactive idiotype associated with anti-lipid A antibodies.
Su SD; Ward MM; Apicella MA; Ward RE
J Immunol; 1990 Nov; 145(9):2994-3001. PubMed ID: 2212671
[TBL] [Abstract][Full Text] [Related]
14. Specificity and cross-reactivity of monoclonal antibodies reactive with the core and lipid A regions of bacterial lipopolysaccharide.
Pollack M; Chia JK; Koles NL; Miller M; Guelde G
J Infect Dis; 1989 Feb; 159(2):168-88. PubMed ID: 2915151
[TBL] [Abstract][Full Text] [Related]
15. Treatment of experimental gram-negative bacterial sepsis with murine monoclonal antibodies directed against lipopolysaccharide.
Priest BP; Brinson DN; Schroeder DA; Dunn DL
Surgery; 1989 Aug; 106(2):147-54; discussion 154-5. PubMed ID: 2763023
[TBL] [Abstract][Full Text] [Related]
16. Superantigen and endotoxin synergize in the induction of lethal shock.
Blank C; Luz A; Bendigs S; Erdmann A; Wagner H; Heeg K
Eur J Immunol; 1997 Apr; 27(4):825-33. PubMed ID: 9130631
[TBL] [Abstract][Full Text] [Related]
17. Dissociation between Limulus neutralisation and in vivo protection in monoclonal antibodies directed against endotoxin core structures.
McConnell JS; Appelmelk BJ; Cohen J
Microb Pathog; 1990 Jul; 9(1):55-9. PubMed ID: 2077344
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.
Bogard WC; Dunn DL; Abernethy K; Kilgarriff C; Kung PC
Infect Immun; 1987 Apr; 55(4):899-908. PubMed ID: 3549565
[TBL] [Abstract][Full Text] [Related]
19. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
[TBL] [Abstract][Full Text] [Related]
20. Protective anti-lipopolysaccharide monoclonal antibodies inhibit tumor necrosis factor production.
Cody CS; Burd RS; Mayoral JL; Dunn DL
J Surg Res; 1992 Apr; 52(4):314-9. PubMed ID: 1593869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
